—
Ascend Ketamine, a ketamine infusion therapy and integrative medicine clinic based in Houston, Texas, launched a new range of ketamine infusion therapies for patients who suffer from chronic pain, depression, PTSD, anxiety, and other conditions. The company’s team of expert physicians offer compassionate care, customizing each session to the patient’s needs and goals, following up with each individual patient post-infusion and providing mood tracking tools to monitor their journey towards wellness.
More information can be found at http://ascendketamine.com.
Many clinical studies from prestigious journals including Biological Psychiatry Journal, the American Journal of Psychiatry and JAMA Psychiatry have proven that ketamine can be 60-80% effective against treatment resistance depression (TRD), and is also effective against chronic pain (CRPS or RSD), fibromyalgia, OCD, PTSD and many more.
For patients suffering from chronic pain, Ascend Ketamine tailors ketamine infusion therapy to each and every patient’s specific needs depending on the nature and severity of the symptoms. In addition, they offer in-home ketamine infusion therapy for people who may be unable to leave their home to receive ketamine infusions.
The company strives to make ketamine infusion therapy accessible to more people by offering the lowest priced ketamine infusions in Texas and beyond and works exclusively with highly-trained emergency physicians, including Lars Thestrup, Darrell Calderon, Barry Diner and Jesus Arroyo, who have decades of combined research and clinical experience.
A spokesperson for the company said: “Our team consists of emergency physicians and hospice doctors with more than 70 years of combined experience working with ketamine and managing psychiatric emergencies in Houston academic centers and community hospitals. We are caring and compassionate to the emotional, mental and physical needs of our patients, ensuring their utmost comfort from the moment they step through our clinic’s doors.”
Interested parties can find more information by visiting the above-mentioned website or by calling +1-832-930-2642.
Release ID: 445029